Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of EMLA Test Patch vs Reference Patch
NCT03313336Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lidocaine 10% oropharyngeal spray and prilocaine in pain (2 arms), sponsored by AstraZeneca. Primary endpoint: Anesthetic efficacy by pain reduction assessment. Started Oct 2017; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayprilocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03313336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03313336.